Korro Bio Statistics
NASDAQ: KRROHealthcareBiotechnologyUSD
10.49+0.73 (+7.48%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Korro Bio by the numbers
Korro Bio has a market capitalization of $154.5 million based on 14.73M shares outstanding. With trailing EPS of $-10.62, Korro Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.8% below its 50-day average and 10.4% below its 200-day average.
Average daily trading volume is 148.67K shares, or about $1.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KRRO valuation vs. peer median
| Metric | KRRO | Peer median | Difference |
|---|---|---|---|
| Market cap | $154.47M | $155.22M | -0% |
| Avg. volume | 148.67K | 682.39K | -78% |
Peer median across 8 companies: CDXS, TARA, CHRS, NERV, ALXO, MENS, VYGR, ABOS.
Valuation
- Market cap
- $154.47M
- EPS (TTM)
- $-10.62
- Shares outstanding
- 14.73M
Price and trading
- Previous close
- 9.76
- Open
- 9.64
- Day range
- 9.50 – 10.63
- 52-week range
- 5.20 – 55.89
- 52-week change
- -78.49%
- Beta
- —
- Volume
- 156.98K
- Average volume
- 148.67K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 154.47M
- Forward Pe
- -2.37
- Eps
- -10.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 55.89
- Week52 Low
- 5.20
- Avg Volume
- 148.67K
- Shares Outstanding
- 14.73M
- Ma50
- 11.90
- Ma200
- 11.71
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -81.23%
- Pct From52w Low
- 101.58%